THE subject proposed for discussion is: "The Value of Ergot in Obstetrical and Gynacological Practice, with Special Reference to its present position in the British Pharmacopceia." I think it is essential for a proper appreciation of the problem that we should have before ts a clear conception of the pharmacology of the drug, and of the available information concerning the chemical properties of its active principles. It is, obviously, my principal function, in a discussion of this kind, to deal with this aspect of the matter.
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The position of ergot in pharmacology and therapeutics is somewhat anomalous. Like many other drugs it owed its introduction into therapeutics to purely empirical observation of its effects. While no definite knowledge existed as to the nature of its active principles, the methods adopted for preparing the extracts, which have passed into official currency, were similarly settled largely by tradition and experience at best vaguely recorded. I cannot take time to-night to deal with the fascinating history of the subject. It is sufficient for our purpose to note that about the middle of the last century two types of preparation came into vogue. In one of these the extraction was begun with water, and to the watery extract a certain proportion of alcohol was added, which carried down what were regarded as impurities; the other preparation was made by a preliminary extraction with alcohol-the alcohol being subsequently diluted with water, and the insoluble residue thereby precipitated being again discarded. These processes appear to have provided the basis for the two commonly used preparations in the British Pharmacopoeia -the so-called extractum ergota? liquidum and extracturn ergota? (or ergotine). I shall have something to say of these preparations later.
The first substance obtained from ergot in a pure condition, which could be regarded as having any probable relation to its pharmacological or therapeutic activity, was the " ergotinine" of Tanret, which was isolated and described as long ago as 1876. This beautifully crystalline alkaloid was associated with a quantity of material appearing to Tanret to have an identical chemical composition, but differing from the crystalline ergotinine in resisting crystallization and in its low specific rotary power. Tanret regarded it as sinmply a physical modification, and described it as " amorphous ergotinine." A mixture of these crystalline and amorphous alkaloids passed into use under the name " ergotinine," and acquired some therapeutic reputation, particularly in France. Presumably the so-called "ergotinine citrate" is still obtainable and still prescribed. I think it is clear, however, that Tanret's conclusion that the two alkaloids were identical delayed for some years a clear understanding of the position. Subsequent workers, wishing to observe the pharmacological action of ergotinine, naturally chose the crystalline form, which could be obtained in a high state of purity, and found that it was practically inert. The position became much clearer when my former colleagues, Barger and Carr, succeeded in purifying the amorphous alkaloid by preparing crystalline salts from it, and were thus able to show that it was chemically different from the crystalline ergotinine closely related to it. My own pharmacological contribution to the joint investigation showed that the amorphous alkaloid yielding crystalline salts, now renamed " ergotoxine," was an intensely active substance possessing the already known toxic actions of ergot-producing gangrene and so forth-and being also the substance responsible for a new and specific action of ergot, which I had shortly before identified. So far as experiments in a laboratory enabled one to judge, ergotoxine might also have been regarded as the principle responsible for the therapeutic action of ergot, since it had a powerful stimulant effect on plain muscle-conspicuously of the arteries and of the uterus.
There were several difficulties, however, in the way of the conclusion that ergotoxine was the sole active therapeutic principle of ergot. I do not think that it can be said that it received thorough and systematic clinical trial, but such trials as were made at the time of its discovery did not arouse any enthusiasm for its therapeutic properties. Again, the majority of practitioners were using, in their obstetrical and gynaecological practice, the preparations of the British Pharmacopceia. The methods indicated for preparing these were such as might almost lead to the suggestion that the aim of those devising them was to exclude ergotoxine, so far as possible, from the official preparations. No such aim, of course, existed. The methods were simply those long hallowed by tradition. But, whatever the origin of these extracts, the fact that they were so 'widely used, with apparent satisfaction, made it very difficult to suppose that the only important principle of ergot was this alkaloid, of which they contained, at best, very small traces. The argument, however, was not a very strong one. A preparation, such as the fluid extract of the United States Pharmacopeeia-an extract made with acidulated alcoholwhich contained a large proportion of the ergotoxine present in the ergot, was standardized by certain producers by its power of producing gangrene of the cock's comb-an ergotoxine effect-and was, apparently,.used with as much satisfaction in America as the liquid extract of ergot of the British Pharmacopoeia was used in England. There were other difficulties, however, created by the claims of other pharmacologists to have discovered methods of measuring the therapeutic value of an ergot extract by laboratory tests. My friend, Professor Dixon, for example, stated that the therapeutic value of a liquid extract of ergot could be measured by its power of raising the arterial blood pressure of the cat; while, somewhat later, Professor Kehrer made the rather plausible claim that the obvious way to measure the therapeutic activity of an ergot preparation was by its stimulant action on isolated uterine muscle. Both these effects, indeed, are effects which ergotoxine produces, but the preparations in which they were being measured by these authorities owed their activities, in these two directions, not to ergotoxine at all-of which they contained hardly any-but to entirely different substances, which my colleague Barger and I were able to identify as the bases tyramine and histamine, which can be produced from the amino-acids tyrosin and histidin by the action of bacteria, which split off carbon dioxide.
An altogether new position was thus created. It was, of course, not difficult to suppose that bases such as these, which are produced by many bacteria, could also be produced by a fungus like ergot. So far as the evidence went, however, it was against the supposition that they were present in the drug itself before it was subjected to the process of extraction. The recent very careful investigations of-Stoll, carried out with very fresh and carefully preserved specimens of ergot, confirm the view that these putrefactive bases are not present in any significant amount in good samples of ergot itself. This conclusion, however, by no means excludes the possibility that ergot preparations, such as those of our Pharmacopaeia, might possess useful activity, due not to the truly specific ergot alkaloids, but to bases such as these, casually produced by the putrefaction, for which the officially prescribed process of preparation provides abundant opportunity. At the same time, there was difficulty in the way of supposing that bases like these, which are undoubtedly present in many articles of diet, and which, further, are certainly produced by bacterial action in the intestine, could have any great therapeutic importance when administered by the mouth in relatively small quantities.
During the last two years a further complication appeared to be introduced into this already tangled problem. Dr. Stoll, already mentioned, a Swiss chemist working on behalf of a Swiss firm, isolated from ergot what appeared, and still appears, to be a new alkaloid. Its properties are in many ways closely similar to those of ergotoxine, but its formula, according to present information, is slightly different, and it has the distinction of being susceptible of crystallization as a free base. Experiments were made on its pharmacological properties, by Professor Spiro of Basel; and a number of trials of its therapeutic properties have already been published in the Swiss and German literature. These, carried out far more systematically than any trials which ergotoxine has ever received, seem to have satisfied the clinical workers concerned that this alkaloid, named "ergotamine " by Stoll, has all the therapeutic effects of good ergot, and produces these effects with more certainty and regularity. On the other hand, Professor Spiro's preliminary investigation did not make at all clear the relation of the pharmacological action of ergotamine to that which I had, some fifteen years ago, described for ergotoxine. I suggested to him that we should exchange preparations, and jointly make the comparison, with the result that we were both perfectly satisfied that, whatever might be their chemical relationship, these two alkaloids were absolutely identical, both qualitatively and quantitatively, in their pharmacological effects.
So far as the subject of our discussion is concerned, we may, therefore, conveniently speak of these two known active alkaloids of ergot-ergotoxine and ergotamineas " the specific ergot alkaloids"; and the problem reduces itself to this: Do the specific alkaloids of ergot give, in obstetrical or gynecological practice, or in both, the effects which the clinical worker wishes to produce when he administers ergot? If so, ergot must be included in the Pharmacopoeia, because these specific alkaloids can be obtained from no other source. But, if ergot is to be retained in the Pharmacopoeia on account of its specific alkaloids, the methods of preparing the official extracts ought to be so revised as to ensure that these alkaloids are present in the finished product, and not thrown away, as at present. If, on the other hand, it is the fact that, with the existing official extracts, the non-specific putrefactive bases which they contain possess all the remedial actions, in obstetrical or gynscological treatment, wvhich ergot is supposed to produce, then it is equally clear that ergot has no proper place in the Pharmacopoeia. These bases are much more easily and cheaply obtainable from other sources, and by other methods, and to provide them, for therapeutic use, by casual and unregulated putrefaction of an obscure and expensive fungus, is not a scientific or even a sensible procedure.
I do not suppose that a discussion such as the present is likely to produce all the necessary data for the final settlement of a question such as this, but I may be allowed, in conclusion, to indicate one or two directions in which the discussion might throw light on the problem. In the first place, it will possibly clarify the issue if I indicate the relation of these known active principles to certain non-official and proprietary preparations.
Ergotinine citrate is a preparation owing its activity entirely to the specific alkaloids. Ergotoxine and its salts, when they were obtainable, were also representatives of the specific alkaloids. The firm for whom Stoll carried out his recent investigations are issuing a solution of ergotamine salts with the name " gynergen " on the European continent, and" femergin " in this country. The action of these solutions again is, of course, purely that of the specific ergot alkaloids. Some years ago, Messrs. Burroughs Wellcome and Company issued, in this country, a preparation to which they gave the name "ernutin." This preparation was an attempt to avoid the difficulty of deciding between the specific alkaloid ergotoxine and one or other of the putrefactive bases, as the essential constituent of ergot, by including them all. During the war, and since then, the practical disappearance from the British market of the ergot from Russia, which was previously the source of ergotoxine, has, apparently, led to a revision of this policy, and a preparation has, if I am correctly informed, been produced in which the non-specific bases are retained, but the unobtainable ergotoxine has been omitted. There may be those present who have had the opportunity of testing both mixtures, and who may be able to say whether the mixture containing the non-specific bases only has any of the activity expected of ergot, and, if so, whether it has as much of that action as the preparation also containing the specific alkaloidergotoxine.
There is one other point which suggests itself to my ignorance as possibly worth consideration. Ergot used to be employed very largely in obstetrical work. I imagine that, in this direction, its use has largely been displaced by that of the pituitary extract. In so far as it is still used, it appears to me that there is just a possibility that the type of ergot action, and, therefore, the type of ergot preparation, which is desirable in obstetrical practice, may be different from those which are required in gyntmcological work, in which, I gather, ergot nowadays finds its principal application. I venture to suggest that the possibility of this distinction may with advantage be kept in view in our discussion.
It is, as I said, almost too much to hope that a discussion like this can finally settle a question of this kind. It will not be fruitless if it makes clear the nature of the question which requires settlement. I feel very strongly that the present position of ergot and its official extracts, in our Pharmacopceia, is something of a reproach to a scientific profession. Possibly, from this discussion, some suggestion may emerge of an organized investigation by which the reproach may be removed.
DISCUSSION.
Sir NESTOR TIRARD said that since the value of ergot was to be discussed with special reference to its present position in the British Phariliacopoeia, he felt it his duty, as one of the editors, to miiake a few remarks upon that subject. In particular he wished to refer to the statement about the methods of preparing the extracts being " those long hallowed by tradition." This appeared to suggest that very little trouble had been taken in the compilation. It might be well to say that before revising the "list of medicines and compounds and the manner of preparing them " (Medical Act of 1858) those responsible took many steps in their endeavour to ascertain the wishes of the medical profession. All the authorities-that is the examining or licensing bodieswere asked to make suggestions for additions, omissions or alterations. Replies were received from nineteen authorities and were tabulated. The detailed views of the Therapeutic Committee of the British Medical Association, the representations of a committee of wholesale firms, and an analysis of some forty-eight thousand recent prescriptions also supplied material of great value. It was found that in no single instance was there any desire to omit ergot or its preparations. One authority suggested the introduction of a stable active principle of ergot, another considered that the preparation of extractum ergotee might be improved, and a third wished the liquid extract to be standardized physiologically. The last was an attractive proposal for preparations of several other drugs besides ergot. In the absence of a State laboratory to establish a standard there were obvious difficulties at the timne the current Pharmacopaeia was undergoing revision. He (Sir Nestor Tirard) expressed full appreciation of the valuable work of Dr. Dale upon ergot. He noticed, however, that Dr. Dale, in a recent report upon pituitary extracts,' had shown that claims of physiological standardization already made on behalf of some five different commercial samples included wide divergencies of activity. An authoritative standard and a State laboratory were essential before it would be possible to introduce pituitary extract into the British Pharmacopaeia, even though pharmacologists and obstetricians might be agreed that it should replace ergot.
Dr. HERBERT SPENCER thought Dr. Dale's paper was of great value, not only in its pharmacological aspect, but also in emphasizing the importance of the collaboration of laboratory and clinical workers. He had had evidence of this at University College Hospital, where, in the laboratory of the medical unit, the discovery of the weakness of a supply of pituitrin had led to its abandonment and the substitution of an efficient brand. He said that Dr. Kellaway had also investigated a new preparation of ergot which showed a very powerful effect; but the uterus did not react to repeated doses. He (Dr. Spencer) had therefore decided not to use it clinically. There was no doubt of the power of liquid extract of ergot to cause the uterus to contract; but for gynmecological bleeding he found the ammoniated tincture much more efficient and had used it exclusively for thirty years. He had therefore been interested to hear Dr. Dale's opinion as to its pharmacological superiority.
Professor W. E. DIXON, F.R.S., regarded as one of the most important advances of the last few years the discovery that the substances that worked the human body were not far removed from the crystalline alkaloids that could be isolated. It appeared likely that the normal stimulus to the uterus was the secretion of the pituitary gland into the cerebro-spinal fluid. An interesting point was that the injection of ovarian extract alone among organic extracts led to the appearance of pituitary secretion in the cerebro-spinal fluid. Corpus luteum did not cause this phenomenon, but the substance I See Lancet, November 25, 1922 November 25, , p. 1134 of the ovary itself did so even after it had been boiled. It would seeill to follow that. uterine contraction was a physiological process brought about by pituitary extract. It was therefore interesting that obstetricians apparently preferred pituitary extract to any other drug for the purpose of stimulating uterine muscle. In Germany in 1915' a number of experiments had been perform-led in which the movements of the human uterus were recorded. A comparison of the effect of ergot with that of pituitary extract showed that after the administration of the latter the pains became quicker, but no difference in tone wtas detectable, whereas after ergot the pains increased and the tone also increased. With regard to the British Pharmacopoia, pharmacologists were clear that the Anmerican liquid extract was far superior to the British liquid extract. Sir Nestor Tirard had intimated that the editors of the British Pharmiiacopeia were out to produce standards of those drugs which were commonly used-i.e., that they were prepared to follow in the wake of, but did not attempt to lead the profession. How, then, should we advance ? Practitioners tended to follow the British Pharmacopceia as an authority guiding them as to which preparations of drugs they should use. In this way a circle was established, fromn which there appeared to be no escape.
Dr. T. W. EDEN (Chairmnan) said that they greatly appreciated Dr. Dale for his very clear and interesting presentation of the subject. Although Dr. Dale had spoken with modesty of his own share in the work which had been done, there was no doubt that he had done a great deal to clear up the confusion which had existed with regard to the active principles of ergot. He (the Chairm-lan) thought that although they now had, in pituitary extract, a reliable substitute for ergot, it would be very unfortunate if ergot disappeared from the Pharmacopeia because it was a miiuch more suitable drug than pituitary extract to place in the hands of niidw%ives. Pituitary extract occasionally produced rather alarmiiing toxic effects, and its potency called for great care when using it, whereas ergot -%Nas free from any risk of producing unfavourable general effects in obstetric practice. The reluctance of clinical workers to discuss the subject was perhaps explained by the deep distrust which they all felt for clinical impressions of the action of drugs. There were so im-any possible sources of error that very great care was called for in attributing clinical phenomena to drugs which had been admllinistered.
In the case of ergot he had always felt that it ought to be possible to devise a method of graphing the uterine contraction in labour by myieans of a bag placed in the cervix, and if the pharmacologist could help themii to work out such a method, the action of both ergot and pituitary could be subjected to an accurate clinical test.
Mr. ALECK BOURNE said that he was now engaged in an attempt to measure accurately and graphically the chaniges of intra-uterine pressure induced by the injection of pituitary extract, on behalf of the Committee appointed by the Council of the Section of Obstetrics and Gynecology for the Investigation of Pituitary Extract in Labour. The apparatus which was made and supervised by Dr. H. H. Dale and Dr. Burn had so far worked very well, and it was hoped that the report of the Committee, when published, would refer to results of real value obtained by this direct method. He further mentioned this work on pituitary extract to suggest a method by which some scientifically accurate evidence of the value of ergot and its derivatives on the human uterus might be obtained, as he had very little confidence in the scientific value of the impressions gained by the clinical administration of the drug. He feared the effects of bias in favour of, or against, the use of a particular drug were too strong-perhaps unconsciously so-to enable the observer to arrive at a scientifically accurate opinion from clinical evidence alone.
Professor HENRY BRIGGS appreciated Dr. Dale's interesting summary of the past of ergot, also his laboratory search for the best in ergot. The drug had attained a varied reputation, and established clinical opinions against its efficacy were readily recalled. Wider co-operation in laboratory and bedside work was rightly advocated by Dr. Dale. Professor Briggs stated that during the past five years he himself had often officially referred to the singular practice in medical schools of issuing daily from the theatre long lists of common and rare operations and of not issuing similar ward nlotices of the medical cases with an indication of the main remedy or drug in use in at SAGE Publications on June 21, 2016 jrs.sagepub.com Downloaded from Sections of Obstetrics and Gynaecology and Therapeutics 7 each. In any medical school, the issue of such medical ward notices was little more than a bare duty to the laboratory of pharmacology; the notices would be welcomed as guides to students and visitors.
Dr. DALE (in reply) said that the position Sir Nestor Tirard had taken up as to the functions of the British Pharmacopceia, was quite intelligible but rather hopeless. The function of the British Pharmacopceia was not to lead but to follow the profession. There would never be progress on those lines, for the profession was apt to regard the British Pharmacopoeia as an authority not only as to what was, but as to what should be, used. In the 1914 British Pharmacopoeia the extract of ergot had been changed from an alcoholic to a watery extract.
Sir NESTOR TIRARD at this point reminded Dr. Dale that the British Pharmacopoeia, was controlled by an international agreement whereby it was compelled to make all liquid extracts watery extracts, alcohol being added subsequently. In America alone, in spite of this agreement, had the alcoholic extract been retained.
Dr. DALE said he wished that the American disobedience had prevailed in this country also, because by other methods the specific active substances in ergot were thrown away and the adventitious substances-he might almost say impurities-were retained. The Chairman (Dr. Eden) had spoken of the advantages of extracting all the active principles of ergot. This would limit the preparation to one containing the alkaloids, since the bases practically did not exist in fresh, clean ergot. Mr. Bourne had been pessimistic as to the help available from clinicians, and Dr. Dale agreed that a Committee reporting to the Section of Obstetrics and Gynmecology would probably be the best method of eliciting any information of value. Presumably the findings of such a committee of obstetricians would carry some weight with the editors of the British Pharmacopceia.
